Last reviewed · How we verify
NCT03166137
Carbon Dioxide Laser and Cryotherapy in Treatment of Warts
NA trial testing Carbon dioxide laser in Common Warts in 60 participants. Status unknown.
1 August 2018
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 August 2017 |
| Primary completion | 1 August 2018 |
| Estimated completion | 1 August 2019 |
Drugs / interventions tested
- Carbon dioxide laser
- Cryotherapy (CRYOTHERAPY) — full drug profile →
Conditions studied
- Common Warts — all drugs for Common Warts →
Sponsor
Assiut University
Who can join
Eligibility, any sex, with Common Warts. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Viral warts are common skin conditions seen in both children and adults. Human papilloma virus is responsible for verrucae. Cutaneous manifestation of the human papillomavirus, are extremely common particularly on the hands and feet. Warts can induce hard, thickened skin, black pinpoints, pain or tenderness with significant morbidity for the patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03166137
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Carbon dioxide laser
Trials testing the same drug.
- NCT05097469 — Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Sexual Dysfunction. · NA · unknown
- NCT03465280 — Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP) · unknown
Other recruiting trials for Common Warts
Currently open trials in the same condition.
- NCT06737406 — Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03166137 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 25 May 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03166137.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing